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Abstract 
 The tumor spheroid is becoming a promising model for cancer preclinical drugs 
test. However, its opacity limits the application of high-resolution imaging modalities 
to explore the inner core region of a spheroid. In this study, a fast aqueous optical 
clearing method, ScaleSQ(5), was applied to tumor spheroids achieving tissue 
transparency for deeper light penetration. The imaging depth enhancement was 
examined by confocal fluorescence microscopy and optical coherence tomography 
respectively. As a result, tissue transparency is achieved and the light penetration is 
enhanced by 61.81% in confocal fluorescence microscopy, and 57.13% in optical 
coherence tomography. Also, ScaleSQ(5) is compatible with many fluorescence dyes 
which makes it promising for inner microstructure exploration of tumor spheroids. 
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1. Introduction 
Cancer is the number-one killer which is claiming millions of lives every year. 
Cancer treatment is a hot topic in biology and it is still in development. However, 
more than 90% of new anti-cancer drugs fail in preclinical test (1) due to the ignoring 
of the interaction of tumor cells with neighboring cells and extracellular matrix 
(ECM) within the human body (2). In recent years, a three-dimensional (3D) in vitro 
model (tumor spheroid) is introduced to mimic the tissue-specific properties for drugs 
testing (1-5).When the tumor spheroid grows to a size larger than 500 μm in 
diameter, it commonly shows a multilayer structure which is important for the 
analysis of nutrient, oxygen, waste transportation and drugs delivery (2). The confocal 
fluorescence microscope is a promising tool to characterize the 3D structure of tumor 
spheroids and providing a high-resolution image of the specific-targeting fluorescence 
image. However, the low penetration of light caused by photon scattering and 
absorption limits the usage of a confocal fluorescence microscope. A standard laser-
scanning confocal microscope can only reach an imaging depth of ~150 μm below 
the brain surface (6) which is insufficient to explore the inner environment of large 
tumor spheroids. 
 Optical coherence tomography (7) is an emerging imaging technology which 
relies on the principle of low-coherence interferometry and could provide a 
noninvasive cross-sectional imaging of biological tissue. OCT could provide 
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transverse resolution and axial resolution of few microns, also, it could reach an 
imaging depth of ~2 mm. The use of OCT has been reported in the previous studying 
for monitoring the growth of tumor spheroid (3, 8). Like the confocal microscope, 
OCT is also able to provide the 3D image of the biological tissue, meanwhile, OCT 
balances the tradeoff between spatial resolution and imaging depth. 
 3D imaging reconstruction of biological tissue is important in morphology, 
pharmacology and in other biology researches. However, there are limited 3D imaging 
modalities available when the size of the sample exceeds the imaging depth of the 
technology. Reducing the light scattering and absorption of tissue could improve 
imaging depth, therefore, making ultrahigh-resolution imaging systems available. 
Optical clearing is a developing technology which could reduce photon scattering and 
absorption effect in the tissue and make the tissue more transparent, so as to improve 
the imaging depth of imaging modality. Although the concept of the optical clearing 
was introduced more than a century ago, this technique is rapidly developing in recent 
years (9). More advanced clearing techniques, with different advantages and 
disadvantages, were introduced, such as 3DISCO, Scale/ScaleS, SeeDB and CLARITY 
(6, 10-12). 
 In my graduate thesis, I imaged tumor spheroid with OCT and confocal 
microscope modalities, using ScaleS which is aqueous clearing reagent, and trying to 
increase the imaging depth for imaging techniques. 
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2. Principle 
2.1 Optical Clearing 
 The first pioneer of optical clearing is a German anatomist Werner Spalteholz and 
the idea was presented in the 1910s (13, 14). The main idea of optical clearing is that 
replacing cell lipid with esters liquid and immersing in another esters liquid for 
refractive index (RI) matching. For example, in Figure 1, a tissue with its own RI, 
labeled with gray color, is immersed in the ester liquid with RI of A, labeled with a light 
pink color. It takes several hours or days for liquid A to permeate into the tissue and 
replace the tissue lipid. The tissue after lipid replacement shows a different RI, labeled 
with the deepest pink. Then, the tissue is transferred to another solution with RI of B, 
labeled with a deeper pink color. The RI of B is similar to the RI of the tissue after lipid 
replacement so that it can increase light penetration and reduce light scattering, so as to 
achieve tissue transparency.  
 
Figure 1. Brief schematic of Optical Clearing protocol. 
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 In previous studies, the benzyl-benzoate-based clearing reagent is frequently used 
(15-18), because it could introduce the high transparency to the tissue. However, this 
ester-based method is reported of incompatibility with many fluorescence probes (19, 
20). Also, the tissue shrinkage is a problem to restore the image for 3D reconstruction 
(6).  
 A new optical clearing, called Scale, was introduced by Dr. Hama and his co-
workers (6). The Scale is a urea-based hydrophilic reagent which could preserve the 
fluorescent signal in the transparent tissue and maintain the size of tissue. Lately, 
another improved technique, named ScaleS was introduced which adds D-sorbitol for 
better preservation of fluorescent signal and for better transparency (21). ScaleS is 
optimized into five solutions, ScaleS0-4, because of the slight difference in constituent 
components, and a fast clearing protocol, called ScaleSQ(0) and ScaleSQ(5). In my 
work, I have tried 3Disco, ScaleS, ScaleSQ(0) and ScaleSQ(5) as a pre-experiment. As 
shown in Table 1, 3Disco has the best transparency but it is unfriendly to fluorescent 
dyes and has longer clearing process. ScaleS and ScaleSQ(0) are compatible to 
fluorescent dye. However, ScaleS took days to proceed and ScaleSQ(0) cannot achieve 
efficient transparency. As a result, I find out that ScaleSQ(5) is a fast clearing protocol, 
meanwhile, maintaining a better transparency on the tissue. 
 
 
6 
 
 3Disco ScaleS ScaleSQ(0) ScaleSQ(5) 
Transparency 
★★★ ★★ ★ ★★ 
Fluorescent Dye 
Compatibility 
★ ★★★ ★★★ ★★★ 
Clearing Time 
★ ★ ★★★ ★★★ 
Table 1. Comparison chart among optical clearing methods. 
 
2.2 OCT 
Low-coherence interferometry has been used for precision measurement since the 
1980s (22). Later, a powerful imaging technique for biological cross-sectional imaging, 
called optical coherence tomography (OCT), was invented. The first demonstration of 
OCT was introduced by Professor James Fujimoto and his research group in 1991 (7) 
which is time-domain OCT (TD-OCT).  
2.2.1 Time-Domain OCT 
The setup of TD-OCT (7) is briefly illustrated in Figure. 2. A low-coherence light, 
emitting by a broadband superluminescent diode, was divided into two arms – a sample 
arm (going to the sample) and a reference arm (reflected by a mirror). Then, the 
backscattering light, with different time delays 𝜏𝑛 (Eq.1.), is collected from the sample 
arm. The different time delays 𝜏𝑛 are induced by the refractive index changing in the 
tissue structure and it can be described as τ =
Δ𝑧
𝑐
, where Δz is the imaging depth of 
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different location and the symbol “c” is the speed of light in vacuum. The sample light 
interferes with the reflected light from the reference arm (Eq.2.), and interference 
fringes occurred. For TD-OCT, the sample’s depth profile (A-scan) is a function of 
fringes’ light intensity (Eq. 3), where Δφ is the phase difference caused by the time 
delays. During each A-scan, the reference mirror should be moving with the scanning 
in the sample for longitudinal scanning in order to keep the optical path differences are 
within the coherent length. By scanning the sample in a linear direction, a cross-
sectional image (B-scan) is acquired. 3D volumetric images are obtained by acquiring 
multiple cross-sectional images (C-scan). 
 𝐸𝑠𝑎𝑚𝑝𝑙𝑒(𝑡) =∑𝐸𝑠𝑎𝑚𝑝𝑙𝑒(𝑡 + 𝜏𝑛)
𝑛
 (1) 
 𝐸𝑡𝑜𝑡𝑎𝑙(𝑡) = 𝐸𝑟𝑒𝑓(𝑡) +∑𝐸𝑠𝑎𝑚𝑝𝑙𝑒(𝑡 + 𝜏𝑛)
𝑛
 (2) 
 𝐼(t) = 𝐼𝑟𝑒𝑓 + 𝐼𝑠𝑎𝑚𝑝𝑙𝑒 + 2√𝐼𝑟𝑒𝑓𝐼𝑠𝑎𝑚𝑝𝑙𝑒cos⁡(Δφ) (3) 
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Figure 2. A brief schematic of TD-OCT. 
2.2.2 Fourier-Domain OCT 
 Few years after the TD-OCT was invented, another advanced OCT technique, 
Fourier-Domain OCT (FD-OCT), was introduced which has faster imaging speed with 
the factor of 100 (23) and enhance the sensitivity by the factor of 30. An additional 
advantage of FD-OCT is that it can acquire one A-scan at one time without moving the 
sample and reference mirror. In other words, the fixed reference arm and sample arm 
could simplify the mechanic's design of the system and make OCT technique possible 
for the clinical application. Like TD-OCT, the FD-OCT also relies on the principle of 
low-coherence interferometry. A broadband laser is used as the light source and the 
reflected light from the sample is a function of frequency. Then, the signal light 
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interferes with the light reflected from the reference mirror and forms the interference 
fringes in the frequency domain. Thus, the depth profile structure can be decoded by 
analyzing the interference fringes, shown in Figure 3. To be more specific, different 
layers in the sample is presented by performing the Fourier Transformation on the 
spectrum fringes, shown in Figure 4. 
The FD-OCT can be grouped into two categories: spectral-domain OCT (SD-OCT) 
and swept-source OCT (SS-OCT). The differences between these two techniques are 
light sources and detectors. SD-OCT uses a continuum broadband laser sources such as 
superluminescence diode (SLD) and supercontinuum laser, and SS-OCT uses a 
broadband narrow-pulse swept laser such as Fourier-domain mode locking laser and 
vertical-cavity surface-emitting laser. On the detection parts, SD-OCT is equipped with 
a spectrometer cooperating with a line scan camera, and SS-OCT utilizes a single 
photodiode with a high-speed data acquisition card.  
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Figure 3. Interference fringes at different optical path differences. Blue line: Fringes at optical path 
difference close to zero. Redline: Fringes at a larger optical path difference. 
 
Figure 4. Fourier Transformation of fringes after phase calibration. Colors are corresponding to the 
Figure 3. 
2.2.2.1 Spectrum-Domain OCT 
 The development of SD-OCT dramatically improved the imaging speed, which 
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made OCT competitive in ophthalmic diagnosis. Figure 5 is the SD-OCT setup diagram 
for ophthalmic imaging (24).  
Here, the SLD is used to generate a broadband spectrum and the light is averagely 
split into the sample path and reference path by a 50-to-50 optical fiber coupler with a 
coupling ration either 50/50 or 90/10 depending on demands. The polarization of the 
light could affect the interference result and it is controlled by the polarization controller. 
A neutral density filter (ND filter) is used to modify the reference arm power in order 
to limit light power at a safety level for ophthalmic imaging. BK7 prisms are applied to 
compensate the dispersion caused by optical components. The x-y galvanometer 
controls the scanning direction in an x-y plane or so-called en face plane. Lights from 
the sample arm and reference arm interfere with each other in the fiber coupler and 
detected by the spectrometer. Then, the encoded spectrum is expanded by the diffraction 
grating and focusing on a line CCD array camera. The number of pixels on the CCD 
array is a key factor that determines the maximum imaging depth of the system. The 
imaging acquisition speed of SD-OCT is determined by the exposure time of the camera.  
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Figure 5. SD-OCT apparatus for ophthalmic application. 
2.2.2.2 Swept-Source OCT 
 Another fast OCT modality, SS-OCT, was introduced in 1997 (25, 26) which uses 
a broadband high-speed wavenumber-tunable laser as light source. The output 
wavenumber is time-encoded and sweeping from 𝜆0  to 𝜆𝑛  averagely, shown as 
Figure 6 (27). The spectrum envelope is still a broadband shape consisting of numerous 
short laser pulse narrowed in both frequency domain and spatial domain. 
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Figure 6. A schematic of output power in wavelength space.  
Figure 7 is an experimental setup for ophthalmic imaging built by Dr. Furukawa 
and his group (28). This setup includes basic components of SS-OCT. It uses a 
reflective Fabry-Perot tunable laser as a light source. Then, the light is divided into 
two arms with a power ratio of 99% to 1%. The path with the lower power is going 
into the k-MZI (Mach-Zehnder Interferometer) to generate a sinusoidal interference 
signal as a sampling clock. Balanced detectors are used to convert the light signal into 
an electrical signal so that the light intensity profile is recorded by a high-speed data 
acquisition card (DAQ card). The sinusoidal signal that k-MZI generated, is to 
synchronize wavenumber scanning from the sept laser and data acquisition from the 
DAQ card. The path with a higher power is going into the OCT-interferometer which 
contains the reference arm and sample arm. The Galvanometer is driven by the digital 
14 
 
to analog converter (D/A converter) and synchronized to the A-scan trigger. The light 
source in SS-OCT system is the key element which determines the scanning speed of 
the system. 
 
 
 
Figure 7. SS-OCT apparatus for ophthalmic application 
 Compared with SD-OCT, SS-OCT has better imaging speed because the laser 
scanning speed is faster than the data acquisition time of the camera in SD-OCT. 
However, SD-OCT has been more matured and stable for commercial application. 
2.3 Confocal Fluorescence Microscope 
 A confocal microscopy is a powerful tool for 3D sectioning imaging. The 
principle of the confocal microscope is introduced in 1955 and patented in 1975 by 
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Dr. Marvin Minsky. A few decades later, the confocal laser scanning microscope 
(CLSM) was invented in the late 1980s (29) which could provide high-resolution 
fluorescent images. Compared with a conventional widefield optical microscope, the 
main improvement of CLSM is that a pair of the conjugated spatial pinhole is applied 
to block the light from the out-of-focus region in the sample so that only the light 
from the focus plane can be presented (30), shown in Figure 8. There are two 
conjugate pinhole apertures positioned in front of the light source and photodetector 
separately. With the combination of numerous fluorescent dye, CLSM can provide the 
multiple labeling images with high resolution and sharp contrast. 
 
Figure 8. The ray tracing schematic of the confocal microscope. The red dashed line shows the focal 
plane. (a) and (c) is the case that the light, coming from the out-of-focus region, is blocked by the 
pinhole filter. (b) is the case that only the light from the focal plane can pass through the pinhole and 
reach the objective lens. 
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3. Method 
3.1 Cells Culture 
 The experiment cell line, Glioblastoma (U-87 MG), was purchased from ATCC. 
Cells were incubated in a flask following the protocol that suppliers provided. The 
culture medium consists of DMEM (Gibco GlutaMax, Thermo Fisher Scientific), 10% 
FBS (Thermo Fisher Scientific) and 1% Antibiotic-Antimycotic (Thermo Fisher 
Scientific). The U-87 MG is incubated with the mixed culture medium and within the 
incubator at 37℃, 95% humidity and 5% 𝐶𝑂2.  
 The preparation of tumor spheroids is following the protocol below: 
1. Remove the culture medium from the culture flask and wash it with 
sterilized PBS (Thermo Fisher Scientific) (heated to 37℃). 
2. Cells are resuspended by adding 1ml trypsin (Thermo Fisher Scientific) into 
the flask for 3 minutes, then the culture medium is added to dilute the 
trypsin. 
3. Transfer the cells suspension to a centrifuge tube and centrifuge at the speed 
of 1200 rpm for 2 minutes. 
4. Pour out the liquid and resuspend cells with culture medium. 
5. Seed cells into an ultra-low attachment 96-well round-bottomed plate 
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(Corning Costar) with the concentration of 3000 cells/mL. 
6. Centrifuge the plate at a speed of 1200 rpm for 10 minutes to gather cells 
to the middle part of the bottom. 
7. The plate is maintained at 37℃, 95% humidity and 5% 𝐶𝑂2 in a culture 
incubator and culture medium is changed every three days. 
3.2 Optical Clearing 
3.2.1 ScaleSQ(5) reagents preparation 
 The ScaleSQ(5) requires two reagents: ScaleSQ(5) and ScaleS4. The ingredient 
formula of reagents is provided in the paper (21) and shown in Table 2. Ingredients are 
added into DI water and the solution is placed into an orbital shaker heated to 60℃ and 
shook at 60 rpm for overnight. 
Ingredients ScaleSQ(5)   ScaleS4 Supplier 
D-Sorbitol (w/v) % 22.5 40 Alfa Aesar 
Glycerol (w/v) % - 10 Amresco 
Urea (M) 9.1 4 Alfa Aesar 
Triton X-100 (w/v) % 5 - Sigma-Alorich 
Dimethylsulfoxide (w/v) % - 20 Sigma-Alorich 
R.I. at 589 nm (27℃) 
1.447 1.437 - 
Table 2. Ingredients formula of ScaleSQ(5) reagents. 
3.2.2 Optical Clearing procedure 
 The experimental protocol is also provided in the paper (21), shown in Figure 9. 
18 
 
Before clearing, tumor spheroids were fixed by 4% PFA (Thermo Fisher Scientific) at 
room temperature for 30 minutes. Then, spheroids were transferred into ScaleSQ(5) 
solution and maintained at 37℃ for 2 hours. Spheroids were ready for imaging after 
immersing in ScaleS4(0) for longer than 2 hours.    
 
Figure 9. Experimental protocol of ScaleSQ(5) 
3.3 OCT Imaging 
 The OCT system that I used is an inverse SD-OCT from Z-lab set up by Lian Duan, 
Shown in Figure 10. This SD-OCT could achieve a transverse resolution of 3.1 μm 
and an axial resolution of 1.8 μm (in air). The 96-well-plate was fixed on the stage, 
and the position was controlled by the 3D micrometer. A broadband light source 
(cBLMD-T-850-HP, Superlum) is used as the light source and a spectrometer (Cobra-S 
800, Wasatch) is used for spectrum detection. This camera could achieve the data 
acquisition speed of 50 μs/A-scan. The galvanometer is controlled by an analog output 
device (PCI-6711, National Instruments).  
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 Image acquisition software was designed by using LabVIEW. Before we run the 
code, some parameters should be input. First, we chose “U-Raster” as the scanning path 
and set the number of A-scan and B-scan as 400 by 400, which means that there are 400 
A-scan in each B-scan, and 400 B-scan in each C-scan. The central wavelength (lambda 
0) is 800 nm and the bandwidth (lambda k) is 200 nm. We set the scanning voltage as 
1.5 mm by 1.5 mm. Here, the scanning voltage doesn’t represent the actual physical 
scanning range. Technically, the actual physical scanning range is determined by the 
pixel size which is measured as 3.23 μm/pixel. Therefore, the physical scanning range 
is the pixel size multiplied by the number of pixels which gives us 1.29 mm by 1.29 
mm in x- y plane. The camera feature is also required: the number of camera pixel – 
2048; the exposure time – 50 μs. Then, click the run button and the scanning image is 
showing on the screen. Adjust the z-micrometer to find the bottom of the well and then 
the tumor spheroid, and move the tumor spheroid to the center using an x-y micrometer. 
The OCT data is acquired by running the LabVIEW software. 
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Figure 10. Experimental setup of SD-OCT. 
 
3.4 Confocal Fluorescence Microscope Imaging 
3.4.1 Fluorescence Dye Staining 
 Before the confocal imaging, a fluorescent dye, CellTracker Green (C7025, 
Thermo Fisher Scientific) with the excitation peak of 492 nm and the emission peak of 
516 nm, was applied to label live cells. The tumor spheroid should be stained before 
the clearing procedure began. I dissolved the lyophilized product in DMSO to a stock 
concentration of 10 mM and diluted the stock solution in serum-free DMEM to a 
working concentration of 20 μM. The working solution was added into empty wells 
and spheroids were transfer to the working solution, maintaining at growth condition 
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for 30 minutes. Then, wash the spheroid in PBS for three times to wash out the 
fluorescence solution. Spheroids were fixed in the 4% PFA for 30 minutes and ready to 
move on the clearing procedure.  
3.4.2 Confocal Microscope  
 The confocal microscopy that I used is Nikon Elipse Ti-E, from Health Research 
Hub. Spheroids were placed on the slide glasses for imaging without cover glasses 
because it could press on the spheroid and cause shape changing. Additionally, 
spheroids should be immersed in the ScaleS4 solution, so I added few drops of 
solution on the slide glasses and it was fixed on the stage. The spheroid was found in 
the focal plane and moved to the center of the view through eyepieces. Then, I turned 
off the bright light and switched the channel to FITC channel (Excitation at 495 nm, 
emission at 519 nm) which is matched to the spectrum window of CellTracker Green. 
Adjust the fine focus wheel to define the top and bottom of spheroids. The 3D dataset 
was acquired by running the software – “NIS-element”, provided by Nikon. 
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4. Results 
 The method that I used to quantitatively evaluate the tissue transparency is to 
calculate the variation of central light intensity along with depth position. To be more 
specific, a small square window, with the size of 20 by 20 pixels, was applied on the 
center spheroids to calculate the average central light intensity per pixel, shown in 
Figure 11. Then, the light attenuation curve of central light intensity, varied within the 
z-direction, was plotted using Matlab. The attenuation distance was defined as the 
length when light intensity drops to the 
1
𝑒2
 of the maximum intensity (31).  
 
Figure 11. Schematic of the average central light intensity extraction. 
4.1 Confocal Imaging 
 The fluorescence signal was detected using confocal fluorescence microscopy with 
a 10X objective lens and saved as 3D datasets. Figure 12 shows en face fluorescence 
images of spheroids and its corresponding light attenuation curves. The left column is 
the spheroid without clearing (Control group) and the right column is the spheroid after 
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clearing (Clearing group). All fluorescence images (figure a-d) were acquired at the 
middle frame in the z-direction and the diameter of spheroids is ~400 μm . The 
corresponding light intensity attenuation curve is shown below images (figure 1-4). In 
the control group, the light intensity of inner part is lower than the intensity of the 
clearing group which means that the fluorescent light in the middle part of spheroids 
can barely penetrate the tissue. Quantitatively, the light attenuation distance is shown 
in Figure 13. The sample size is 8 spheroids for the control group and 9 spheroids for 
the clearing group. In the control group, the mean attenuation distance is 113.23⁡μm 
with the standard deviation of 12.02 μm. In the clearing group, the mean attenuation 
distance is 183.22 μm with the standard deviation of 17.53 μm. The result shows that 
the ScaleSQ(5) can enhance light attenuation distance, in other words, light penetration 
by 61.81% in confocal fluorescence microscopy imaging. 
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Figure 12. Fluorescence images at the middle frame of spheroids with the step size of 10 μm/frame. 
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Figure 13. The averaged light attenuation distance in Confocal Imaging. 
4.2 OCT Imaging 
 The OCT images were acquired by SD-OCT with a 10X objective lens and saved 
as 3D datasets. The original data was cross-sectional images and turned to the en face 
plane using Fiji – ImageJ (32). Then, the light attenuation curve is plotted using Matlab. 
The diameter of spheroids is ~ 500 μm. Unlike confocal microscopy, the OCT’s focal 
plane is fixed while acquiring the 3D image. Therefore, before the data acquisition, I 
kept the focal plane remained in the middle of spheroids for both control group and 
clearing group. Figure 14 is the cross-sectional image of spheroids and its 
corresponding light attenuation curves. The left column is the control group and the 
right column is the clearing group. The red dashed line shows the path that the light 
intensity was computed on. In the control group, the light intensity was strong at the 
top surface and vanished quickly along the z-direction. On the contrary, the light 
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intensity in the clearing group was uniformly distributed along the depth profile. One 
important feature here is that the clearing group has weaker light intensity than the 
control group. It is because the transparency of cleared spheroids enhanced light 
penetration and reduced backscattering light which is essential in image contrast. The 
light intensity attenuation distance is showing in Figure 15. The sample size is 6 
spheroids for the control and clearing group. In the control group, the mean attenuation 
distance is 334.33μm with the standard deviation of 39.5 μm. In the clearing group, 
the mean attenuation distance is 525.33 μm with the standard deviation of 24.35 μm. 
The result shows that the ScaleSQ(5) can enhance light attenuation distance, in other 
words, light penetration by 57.13% in OCT imaging. 
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Figure 14. Cross-sectional images at the middle frame of spheroids. Scale bar here is 200 μm.  
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Figure 15. The averaged light attenuation distance in OCT Imaging. 
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5. Conclusion & Future work 
 High-resolution imaging modalities are important in exploring the microstructure 
of 3D tumor spheroids because tumor’s growth dynamics is highly related to its 
morphological structure. However, the light scattering and absorption effect in tissue 
limit the usage of many high-resolution imaging technologies in the tumor spheroids 
research. Optical clearing methods can induce tissue transparency which could reduce 
light scattering and absorption and enhance light penetration in tissue. In my pre-
experiments, I have tried 3Disco, ScaleS, ScaleSQ(0) and ScaleSQ(5) as a pre-
experiment. It showed that the ScaleSQ(5) is more promising for tumor spheroids 
because of its fast clearing protocol with good transparency achieved and compatibility 
to fluorescence probes. Then, tumor spheroids were cleared by following ScaleSQ(5) 
and imaged with confocal fluorescence microscopy and OCT respectively. As a result, 
this clearing method could improve light penetration by 61.81% in confocal microscopy 
and 57.13% in OCT. The tumor spheroid could achieve ~40% transparency observing 
through the naked eyes. Low image contrast in OCT also indicates the transparency 
achieved in tissue. Moreover, the strong fluorescence signal showing in confocal 
images indicates that ScaleSQ(5) is compatible to Celltracker Green fluorophore.  
 ScaleSQ(5) turned lipophilicity spheroids into hydrophilicity which is fluorophore-
friendly. However, the aqueous spheroids show repellency in histology sectioning and 
caused bubbles in paraffin wax while embedding. One possible solution is that recover 
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spheroids lipophilicity by doing the reverse ScaleSQ(5) procedure. It is promising 
because, from the principle of optical clearing, we can not only replace the lipid inside 
the tissue but also replace ScaleSQ(5) solution by immersing in 4% PFA.  
 Besides, I have tried Propidium iodide (Thermo Fisher Scientific) and Live-or-Dye 
(Biotium) to stain the necrotic core in spheroids and found out that Live-or-Dye is a 
fixable dye for optical clearing. In the future work, the optical clearing can induce tissue 
transparency and make confocal microscopy available for inner necrotic fluorescence 
imaging. By using Celltracker Green and Live-or-Dye fluorescent dye, it is promising 
to image a clear picture in the necrotic region with distinguishable boundary. Moreover, 
We could also use OCT to quantify the necrotic region in spheroids and make a 
comparison with confocal imaging. 
 
 
 
 
 
 
 
31 
 
References 
1. Hickman JA, Graeser R, de Hoogt R, Vidic S, Brito C, Gutekunst M, et al. Three‐dimensional 
models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex 
vivo. Biotechnology journal. 2014;9(9):1115-28. 
2. Lin RZ, Chang HY. Recent advances in three‐dimensional multicellular spheroid culture for 
biomedical research. Biotechnology journal. 2008;3(9‐10):1172-84. 
3. Huang Y, Wang S, Guo Q, Kessel S, Rubinoff I, Chan LL-Y, et al. Optical coherence tomography 
detects necrotic regions and volumetrically quantifies multicellular tumor spheroids. Cancer research. 
2017;77(21):6011-20. 
4. Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug 
discovery today. 2013;18(5-6):240-9. 
5. Mueller-Klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical 
applications. American Journal of Physiology-Cell Physiology. 1997;273(4):C1109-C23. 
6. Hama H, Kurokawa H, Kawano H, Ando R, Shimogori T, Noda H, et al. Scale: a chemical 
approach for fluorescence imaging and reconstruction of transparent mouse brain. Nature neuroscience. 
2011;14(11):1481. 
7. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence 
tomography. science. 1991;254(5035):1178-81. 
8. Sharma M, Verma Y, Rao K, Nair R, Gupta P. Imaging growth dynamics of tumour spheroids 
using optical coherence tomography. Biotechnology letters. 2007;29(2):273-8. 
9. Lagerweij T, Dusoswa SA, Negrean A, Hendrikx EM, de Vries HE, Kole J, et al. Optical clearing 
and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor 
microenvironment. Angiogenesis. 2017;20(4):533-46. 
10. Chung K, Deisseroth K. CLARITY for mapping the nervous system. Nature methods. 
2013;10(6):508. 
11. Ke M-T, Fujimoto S, Imai T. SeeDB: a simple and morphology-preserving optical clearing agent 
for neuronal circuit reconstruction. Nature neuroscience. 2013;16(8):1154. 
12. Ertürk A, Becker K, Jährling N, Mauch CP, Hojer CD, Egen JG, et al. Three-dimensional imaging 
of solvent-cleared organs using 3DISCO. Nature protocols. 2012;7(11):1983. 
13. Spalteholz W. Über das Durchsichtigmachen von menschlichen und tierischen Präparaten und 
seine theoretischen Bedingungen, nebst Anhang: Über Knochenfärbung: S. Hirzel; 1914. 
14. Spalteholz W. Über das Durchsightigmachen von menschlichen und tierischen Präparaten: nebst 
Anhang, Über Knochenfärbung: Verlag von S. Hirzel; 1911. 
15. Dodt H-U, Leischner U, Schierloh A, Jährling N, Mauch CP, Deininger K, et al. Ultramicroscopy: 
three-dimensional visualization of neuronal networks in the whole mouse brain. Nature methods. 
2007;4(4):331. 
16. Jährling N, Becker K, Dodt H-U. 3D-reconstruction of blood vessels by ultramicroscopy. 
Organogenesis. 2009;5(4):227-30. 
17. Becker K, Jährling N, Saghafi S, Dodt H-U. Immunostaining, dehydration, and clearing of mouse 
embryos for ultramicroscopy. Cold Spring Harbor Protocols. 2013;2013(8):pdb. prot076521. 
32 
 
18. Oldham M, Sakhalkar H, Oliver T, Johnson GA, Dewhirst MW. Optical clearing of unsectioned 
specimens for three-dimensional imaging via optical transmission and emission tomography. Journal of 
biomedical optics. 2008;13(2):021113. 
19. Yushchenko DA, Schultz C. Geklärte Gewebeproben für die optische Anatomie. Angewandte 
Chemie. 2013;125(42):11151-4. 
20. Kuwajima T, Sitko AA, Bhansali P, Jurgens C, Guido W, Mason C. ClearT: a detergent-and 
solvent-free clearing method for neuronal and non-neuronal tissue. Development. 2013;140(6):1364-8. 
21. Hama H, Hioki H, Namiki K, Hoshida T, Kurokawa H, Ishidate F, et al. ScaleS: an optical 
clearing palette for biological imaging. Nature neuroscience. 2015;18(10):1518. 
22. Youngquist RC, Carr S, Davies DE. Optical coherence-domain reflectometry: a new optical 
evaluation technique. Optics letters. 1987;12(3):158-60. 
23. Wojtkowski M. High-speed optical coherence tomography: basics and applications. Applied 
optics. 2010;49(16):D30-D61. 
24. Potsaid B, Gorczynska I, Srinivasan VJ, Chen Y, Jiang J, Cable A, et al. Ultrahigh speed 
spectral/Fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second. Optics 
express. 2008;16(19):15149-69. 
25. Haberland U, Jansen P, Blazek V, Schmitt HJ, editors. Optical coherence tomography of scattering 
media using frequency-modulated continuous-wave techniques with tunable near-infrared laser. 
Coherence Domain Optical Methods in Biomedical Science and Clinical Applications; 1997: 
International Society for Optics and Photonics. 
26. Chinn S, Swanson E, Fujimoto J. Optical coherence tomography using a frequency-tunable 
optical source. Optics letters. 1997;22(5):340-2. 
27. de Boer JF, Leitgeb R, Wojtkowski M. Twenty-five years of optical coherence tomography: the 
paradigm shift in sensitivity and speed provided by Fourier domain OCT. Biomedical optics express. 
2017;8(7):3248-80. 
28. Furukawa H, Hiro-Oka H, Satoh N, Yoshimura R, Choi D, Nakanishi M, et al. Full-range imaging 
of eye accommodation by high-speed long-depth range optical frequency domain imaging. Biomedical 
optics express. 2010;1(5):1491-501. 
29. White J, Amos W. Confocal microscopy comes of age. Nature. 1987;328(6126):183. 
30. Rolf T. Borlinghaus. Confocal Microscopy: Leica Microsystems,; 2011 [Available from: 
https://www.leica-microsystems.com/science-lab/confocal-microscopy/. 
31. Hecht E. Optics 4th edition. Optics, 4th Edition, Addison Wesley Longman Inc, 1998. 1998. 
32. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-
source platform for biological-image analysis. Nature methods. 2012;9(7):676. 
 
 
 
33 
 
Vita  
Jinyun Zou was born to Qiuping Zou and Jinhong Chi in Heyuan, Guangdong, 
China on September 22th, 1993. He graduated from Shenzhen University and received 
the degree of Bachelor of Science in Optoelectronic Engineering in the Summer of 2016 
and he started his graduate study at Lehigh University in 2016 Fall. He joined in the 
group, Z-lab, during the summer of 2017 and started research as a research assistance 
under the supervising of Professor Chao Zhou. After received his master’s degree, he 
will pursue the Ph.D. degree at Lehigh University in the future. 
